Characterization and significance of urinary fibrin degradation products.

[1]  J. Petrie,et al.  Serum and Urinary Fibrin/Fibrinogen Degradation Products in Glomerulonephritis , 1971, British medical journal.

[2]  P. Kincaid‐smith,et al.  Degradation products and the role of coagulation in "persistent" glomerulonephritis. , 1971, Annals of internal medicine.

[3]  C. Goldsmith,et al.  Characterization of proteins in urinary casts. Fluorescent-antibody identification of Tamm-Horsfall mucoprotein in matrix and serum proteins in granules. , 1971, The New England journal of medicine.

[4]  I. Nilsson,et al.  KIDNEY TRANSPLANTATION AND FIBRINOLYTIC SPLIT PRODUCTS IN SERUM AND URINE , 1970, Transplantation.

[5]  E. N. Wardle,et al.  Study of Proteins and Fibrinolysis in Patients with Glomerulonephritis , 1970, British medical journal.

[6]  A. Pesce,et al.  Selectivity of proteinuria: an evaluation of the immunochemical and gel filtration techniques. , 1970, The Journal of laboratory and clinical medicine.

[7]  P. Kincaid‐smith,et al.  Dipyridamole and Anticoagulants in Renal Disease due to Glomerular and Vascular Lesions A New Approach to Therapy , 1970, The Medical journal of Australia.

[8]  J. Briggs,et al.  The role of fibrinogen in renal disease. 3. Fibrinolytic and anticoagulant treatment of nephrotoxic serum nephritis in mice. , 1969, The Journal of laboratory and clinical medicine.

[9]  E. Israels,et al.  Fibrinogen breakdown products: identification and assay in serum and urine. , 1969, The Journal of laboratory and clinical medicine.

[10]  H. Kwaan,et al.  Plasminogen activator activity in cultures from human tissues. An immunological and histochemical study. , 1969, The Journal of clinical investigation.

[11]  H. Kwaan,et al.  The role of fibrinogen in renal disease. I. Production of experimental lesions in mice. , 1969, The Journal of laboratory and clinical medicine.

[12]  H. Kwaan,et al.  The role of fibrinogen in renal disease. II. Effect of anticoagulants and urokinase on experimental lesions in mice. , 1969, The Journal of laboratory and clinical medicine.

[13]  E. Stiehm,et al.  Split products of fibrin in human renal disease. , 1969, The American journal of medicine.

[14]  V. Marder,et al.  High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. , 1969, The Journal of biological chemistry.

[15]  P. Kincaid‐smith,et al.  Anticoagulants in "irreversible" acute renal failure. , 1968, Lancet.

[16]  E. Becker,et al.  Proteinuria after Albumin Infusion in Patients with Renal Disease∗ , 1968, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[17]  S. P. Miller,et al.  Degradation of Fibrinogen by Proteolytic Enzymes , 1968, Thrombosis and Haemostasis.

[18]  W. Braun,et al.  Urine fibrinogen fragments in human renal allografts. A possible mechanism of renal injury. , 1968, The New England journal of medicine.

[19]  A. Fletcher,et al.  Immunoelectrophoretic characterization of plasma fibrinogen derivatives in patients with pathological plasma proteolysis. , 1967, The Journal of laboratory and clinical medicine.

[20]  A. Y. Chen,et al.  Fibrinogen metabolism and distribution in patients with the nephrotic syndrome. , 1967, The Journal of laboratory and clinical medicine.

[21]  H. Kwaan,et al.  Origin of fibrinolytic activity in cultures of the human kidney. , 1967, The Journal of laboratory and clinical medicine.

[22]  R. Reisfeld,et al.  A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis. , 1967, Analytical biochemistry.

[23]  V. Marder,et al.  The importance of intermediate degradation products of fibrinogen in fibrinolytic hemorrhage. , 1967, Transactions of the Association of American Physicians.

[24]  A. Fletcher,et al.  The proteolysis of fibrinogen by plasmin: the identification of thrombin-clottable fibrinogen derivatives which polymerize abnormally. , 1966, The Journal of laboratory and clinical medicine.

[25]  P. Vassalli,et al.  An immunofluorescent study of pathogenic mechanisms in glomerular diseases. , 1966, The New England journal of medicine.

[26]  K. Lange,et al.  Routine immunohistology in renal diseases. , 1966, Annals of internal medicine.

[27]  D. Koffler,et al.  Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. II. Acute, subacute, and chronic glomerulonephritis. , 1965, The Journal of clinical investigation.

[28]  J. Hardwicke.  Estimation of renal permeability to protein on Sephadex G 200. , 1965, Clinica chimica acta; international journal of clinical chemistry.

[29]  A. Fray,et al.  Protective Action of Heparin in Experimental Immune Nephritis , 1965, Nature.

[30]  B. Davis.  DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS * , 1964, Annals of the New York Academy of Sciences.

[31]  J. Cameron,et al.  SELECTIVITY OF PROTEIN EXCRETION IN PATIENTS WITH THE NEPHROTIC SYNDROME. , 1964, The Journal of clinical investigation.

[32]  P. Vassalli,et al.  THE PATHOGENIC ROLE OF FIBRIN DEPOSITION IN IMMUNOLOGICALLY INDUCED GLOMERULONEPHRITIS * , 1964, Annals of the New York Academy of Sciences.

[33]  T. Astrup,et al.  An Activator of Plasminogen in Normal Urine.∗ , 1952, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[34]  T. Astrup,et al.  The fibrin plate method for estimating fibrinolytic activity. , 1952, Archives of biochemistry and biophysics.

[35]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.